More sponsors and CROs are seeking to conduct decentralized clinical trials (DCTs) than ever before. Which phase, which therapeutic area, which technologies, what is the right study design, how do we scale, what are the cost implications, and which countries should I target? The answers to these questions not only require a strong technology platform, but also require the right consulting expertise to guide implementation strategy.
Research organizations are now embracing the potential of DCTs to take advantage of their potential advantages, such as higher patient engagement, optimized study enrollment, and patient retention. Join IDC’s Vice President of Life Sciences R&D Strategy and Technology, Nimita Limaye, and THREAD’s CEO John Reites as they discuss “how” to win with the strategic implementation of DCTs.
Dr. Nimita Limaye, Research Vice President, Life Sciences R&D Strategy and Technology, IDC
Dr. Nimita Limaye leads the Life Sciences R&D Strategy and Technology program at IDC, providing research-based advisory and consulting services, as well as market analysis. She is passionate about the interplay of data, technology and analytics in transforming R&D. She is an executive business leader, thought leader and influencer, with over two decades of life sciences leadership experience working across the pharma/CRO/life sciences-tech consulting industry.
She has served as a mentor for start-ups on the Mass Bio Digital Health initiative, as the past chair of the SCDM board and is the current chair of the DIA global medical writing community. She has chaired several conferences, led industry roundtables, given keynote talks, led panel discussions and has authored over 70 publications/white papers, several of which focused on decentralized clinical trials.Message Presenter
John Reites, CEO, THREAD
Executive intrapreneur turned digital health entrepreneur, John’s career includes 18+ years’ experience leading global drug development, clinical research and decentralized trials for life science organizations.
As CEO of THREAD, he leads their efforts to change the way clinical research is conducted focused on decentralized approaches, enabling the use of their one platform for conducting modern research studies and leading partnerships with their customers. After launching and growing THREAD, they were acquired in 2019 by JLL Partners and Water Street with strategic investment for continued growth and focus on accelerating drug development for their customers.
Named one of the Top 100 Influencers in Digital Health, John also provides expertise and execution experience in digital health, clinical trials and decentralized, remote, virtual, and community-based clinical research.
He enjoys being a keynote speaker at global industry events, guest lecturer at Duke University on digital health/innovation/entrepreneurship and a published author featured in various conferences, journals, articles and media outlets.Message Presenter
Noah Goodson, Associate Director, Consulting, THREAD
Prior to joining THREAD, Noah helped early-stage biotech and medical device companies design and execute hybrid and fully decentralized research. He is well versed in the complex needs of these organizations and has spent significant time in guiding business development and scientific communication strategies with investors. As part of THREAD Consulting, Noah applies practical experience in running trials with a decentralized approach to build more efficient and inclusive studies.Message Presenter
Who Should Attend?
- Clinical Research
- Clinical Project Managers
- Data Management
- Decentralized/Remote/Virtual Trials
- Digital Innovation/Strategy
- Medical Director
- Patient Experience
- Patient Engagement
- Patient Recruitment
- Trial Design
- Therapeutic Head/Lead
What You Will Learn
- Key strategies to scale DCTs by optimizing study design
- Improving patient engagement and retention
- Enabling better diversity and inclusivity with a DCT approach
- Understanding the change management needed to help DCTs succeed
- Choosing partners who can help implement the DCT mission
THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth Virtual Visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit us at https://www.threadresearch.com/